No Data
This Thursday marks the start of the "soul negotiation" for medical insurance. Which companies are likely to be selected?
According to the National Medical Insurance Administration, a press conference will be held at 10 a.m. on November 28 at the National Medical Insurance Administration to announce the adjustments to the national medical insurance pharmaceutical catalog for 2024 and answer questions from reporters. This means that the results of the national negotiation for medical insurance centralized purchasing in 2024 will be announced this Thursday.
Many innovative drugs stocks in Hong Kong suddenly soared!
On the morning of November 25, the hang seng index fell slightly, while the Hong Kong stock market's biomedical sector performed well. Notably, several biomedical companies saw their stock prices rise significantly due to recent news of major collaboration advancements.
TOT BIOPHARM International Swings to Profit in Nine Months to September; Shares Slide 6%
Tongyao Pharmaceutical (01875.HK) net profit for the first nine months was 35.4 million RMB, turning from a loss to a profit.
Dongyang Pharmaceutical - B (01875.HK) announced the financial data for the nine months ending in September, with revenue of 0.809 billion RMB (the same below), an annual increase of 49.3%. Recorded a net profit of 35.4 million yuan, compared to a loss of 32.39 million yuan in the same period last year, turning losses into profits.
Dongyao Pharmaceutical - B (01875) revenue in the first three quarters increased by 49% year-on-year to 0.809 billion yuan.
Dongyao Pharmaceuticals - B (01875) announced that as of the nine months ended September 30, 2024, the Group's revenue...
Express News | National Medical Products Administration: Deploys pilot work on segmented production reform of biological products.
No Data
